NovaBridge Biosciences - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US44975P1030
1,48 € ↑0,02 (1,37%)
2026-06-04
DEL PRIS
SecurityDE:0VY / NovaBridge Biosciences - Depositary Receipt (Common Stock)
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership68,849 shares
Latest Disclosed Value $ 169,368
Geode Capital Management, Llc reports 52.71% increase in ownership of 0VY / NovaBridge Biosciences - Depositary Receipt (Common Stock)

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 68,849 shares of NovaBridge Biosciences - Depositary Receipt (Common Stock) (DE:0VY) valued at $132,879 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 45,084 shares of NovaBridge Biosciences - Depositary Receipt (Common Stock). This represents a change in shares of 52.71% during the quarter. The current value of the position is $101,897 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVABRIDGE BIOSCIENCES SPONSORED ADS 44975P103 68,849 23,765 52.71 169 -5.59 0.0000
2026-02-09 2025-12-31 13F NOVABRIDGE BIOSCIENCES SPONSORED ADS 44975P103 45,084 -9,478 -17.37 179 -13.11 0.0000
2025-11-12 2025-09-30 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 54,562 0 0.00 206 56.06 0.0000
2025-08-08 2025-06-30 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 54,562 32,525 147.59 132 633.33 0.0000
2025-05-13 2025-03-31 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 22,037 0 0.00 18 0.00 0.0000
2025-02-12 2024-12-31 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 22,037 0 0.00 19 -33.33 0.0000
2024-11-12 2024-09-30 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 22,037 -12,310 -35.84 27 -52.63 0.0000
2024-08-09 2024-06-30 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 34,347 0 0.00 57 -9.52 0.0000
2024-05-13 2024-03-31 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 34,347 0 0.00 64 -3.08 0.0000
2024-02-13 2023-12-31 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 34,347 0 0.00 65 44.44 0.0000
2023-11-13 2023-09-30 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 34,347 -213 -0.62 45 -56.31 0.0000
2023-08-11 2023-06-30 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 34,560 -208 -0.60 103 -14.17 0.0000
2023-05-15 2023-03-31 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 34,768 -18,997 -35.33 120 0.0000
2023-02-13 2022-12-31 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 53,765 23,855 79.76 0 -100.00 0.0000
2022-11-14 2022-09-30 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 29,910 -13,595 -31.25 119 -75.76 0.0000
2022-08-12 2022-06-30 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 43,505 -137,809 -76.01 491 -83.22 0.0001
2022-05-13 2022-03-31 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 181,314 6,017 3.43 2,926 -64.55 0.0004
2022-02-11 2021-12-31 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 175,297 18,197 11.58 8,253 -27.07 0.0010
2021-11-12 2021-09-30 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 157,100 18,009 12.95 11,316 -2.41 0.0015
2021-08-13 2021-06-30 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 139,091 128,599 1,225.69 11,596 2,182.68 0.0016
2021-05-12 2021-03-31 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 10,492 0 0.00 508 2.83 0.0001
2021-02-12 2020-12-31 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 10,492 5,154 96.55 494 96.81 0.0001
2020-11-13 2020-09-30 13F I-MAB-SPONSORED ADR SPONSORED ADS 44975P103 5,338 5,338 251 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.